ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

Three Nurse Awards Made In Self Care

September 30, 1988

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994